PortfoliosLab logoPortfoliosLab logo
GHM vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GHM vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Corporation (GHM) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GHM achieves a 65.20% return, which is significantly higher than LLY's -0.64% return. Over the past 10 years, GHM has underperformed LLY with an annualized return of 20.71%, while LLY has yielded a comparatively higher 32.48% annualized return.


GHM

1D
6.74%
1M
11.93%
YTD
65.20%
6M
87.94%
1Y
169.59%
3Y*
110.60%
5Y*
48.85%
10Y*
20.71%

LLY

1D
-1.67%
1M
10.66%
YTD
-0.64%
6M
2.07%
1Y
43.44%
3Y*
34.95%
5Y*
40.65%
10Y*
32.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GHM vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GHM
Graham Corporation
65.20%44.43%134.42%97.19%-22.67%-15.50%-28.39%-2.28%10.81%-3.80%
LLY
Eli Lilly and Company
-0.64%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between GHM and LLY is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Mar 18, 1992

0.10

Fundamentals

Market Cap

GHM:

$1.18B

LLY:

$953.37B

EPS

GHM:

$1.34

LLY:

$28.14

PE Ratio

GHM:

78.98

LLY:

37.81

PEG Ratio

GHM:

1.54

LLY:

0.76

PS Ratio

GHM:

4.96

LLY:

13.23

PB Ratio

GHM:

9.02

LLY:

30.56

Total Revenue (TTM)

GHM:

$237.56M

LLY:

$72.25B

Gross Profit (TTM)

GHM:

$58.50M

LLY:

$59.75B

EBITDA (TTM)

GHM:

$19.22M

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GHM vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHM
GHM Risk / Return Rank: 9494
Overall Rank
GHM Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
GHM Sortino Ratio Rank: 9191
Sortino Ratio Rank
GHM Omega Ratio Rank: 9090
Omega Ratio Rank
GHM Calmar Ratio Rank: 9797
Calmar Ratio Rank
GHM Martin Ratio Rank: 9696
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7272
Overall Rank
LLY Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 6969
Sortino Ratio Rank
LLY Omega Ratio Rank: 7070
Omega Ratio Rank
LLY Calmar Ratio Rank: 7373
Calmar Ratio Rank
LLY Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GHM vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Corporation (GHM) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GHMLLYDifference

Sharpe ratio

Return per unit of total volatility

3.37

1.15

+2.22

Sortino ratio

Return per unit of downside risk

3.36

1.71

+1.64

Omega ratio

Gain probability vs. loss probability

1.44

1.23

+0.21

Calmar ratio

Return relative to maximum drawdown

9.28

1.92

+7.37

Martin ratio

Return relative to average drawdown

22.87

4.78

+18.09

GHM vs. LLY - Sharpe Ratio Comparison

The current GHM Sharpe Ratio is 3.37, which is higher than the LLY Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of GHM and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GHMLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.37

1.15

+2.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.00

1.25

-0.24

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.46

1.08

-0.62

Sharpe Ratio (All Time)

Calculated using the full available price history

0.25

0.57

-0.32

Drawdowns

GHM vs. LLY - Drawdown Comparison

The maximum GHM drawdown since its inception was -86.11%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for GHM and LLY.


Loading charts...

Drawdown Indicators


GHMLLYDifference

Max Drawdown

Largest peak-to-trough decline

-86.11%

-68.24%

-17.87%

Max Drawdown (1Y)

Largest decline over 1 year

-18.21%

-23.64%

+5.43%

Max Drawdown (3Y)

Largest decline over 3 years

-46.46%

-34.48%

-11.98%

Max Drawdown (5Y)

Largest decline over 5 years

-54.28%

-34.48%

-19.80%

Max Drawdown (10Y)

Largest decline over 10 years

-74.83%

-34.48%

-40.35%

Current Drawdown

Current decline from peak

0.00%

-5.56%

+5.56%

Average Drawdown

Average peak-to-trough decline

-47.42%

-19.22%

-28.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.39%

9.48%

-2.09%

Volatility

GHM vs. LLY - Volatility Comparison

Graham Corporation (GHM) has a higher volatility of 12.76% compared to Eli Lilly and Company (LLY) at 9.11%. This indicates that GHM's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GHMLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.76%

9.11%

+3.65%

Volatility (6M)

Calculated over the trailing 6-month period

36.77%

26.83%

+9.94%

Volatility (1Y)

Calculated over the trailing 1-year period

50.67%

37.88%

+12.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.93%

32.79%

+16.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.99%

30.15%

+14.84%

Dividends

GHM vs. LLY - Dividend Comparison

GHM has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.61%.


PositionTTM20252024202320222021202020192018201720162015
GHM
Graham Corporation
0.00%0.00%0.00%0.00%0.00%3.54%2.90%1.92%1.66%1.72%1.63%1.90%
LLY
Eli Lilly and Company
0.61%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

GHM vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Graham Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
56.70M
19.80B
(GHM) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

GHM vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Graham Corporation and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
23.8%
79.0%
Portfolio components
GHM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Graham Corporation reported a gross profit of 13.47M and revenue of 56.70M. Therefore, the gross margin over that period was 23.8%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

GHM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Graham Corporation reported an operating income of -219.00K and revenue of 56.70M, resulting in an operating margin of -0.4%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

GHM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Graham Corporation reported a net income of 2.85M and revenue of 56.70M, resulting in a net margin of 5.0%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


GHM and LLY have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GHM has higher volatility (12.76%) compared to LLY (9.11%). In terms of maximum drawdown, GHM dropped -86.11% vs LLY's -68.24%.

GHM currently has the higher Sharpe Ratio (3.37 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GHM and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer